- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 5/00 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patent holdings for IPC class C07K 5/00
Total number of patents in this class: 1048
10-year publication summary
|
86
|
65
|
58
|
53
|
34
|
37
|
17
|
17
|
12
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19493 |
24 |
| Centre National de La Recherche Scientifique | 10068 |
9 |
| Protagonist Therapeutics, Inc. | 142 |
9 |
| Novartis AG | 11289 |
8 |
| Massachusetts Institute of Technology | 9909 |
8 |
| The Johns Hopkins University | 5524 |
8 |
| Northwestern University | 3272 |
8 |
| The University of British Columbia | 1465 |
8 |
| Bicyclerd Limited | 138 |
8 |
| Wisconsin Alumni Research Foundation | 3819 |
7 |
| Arrowhead Pharmaceuticals, Inc. | 294 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2533 |
7 |
| Onyx Therapeutics, Inc. | 71 |
7 |
| The General Hospital Corporation | 4642 |
6 |
| Adocia | 141 |
6 |
| Emulate, Inc. | 228 |
6 |
| Oncotherapy Science, Inc. | 297 |
6 |
| SeaGen Inc | 581 |
6 |
| President and Fellows of Harvard College | 5905 |
5 |
| The Trustees of the University of Pennsylvania | 4255 |
5 |
| Other owners | 890 |